Main Article Content

Abstract

The main point of this paper is to address the rising statistics that represent the prevalence of mental disorders in our society. The focus is generally limited to the American public. It is stressed to seek healthy coping mechanisms to relieve mental discomfort or the side effects faced by serious mental illnesses such as major depressive disorder and bipolar disorder, this is so that negative coping won’t be used leading to healthy coping methods to combat mental pain. This is important in order to prevent a high risk for health and well-being if addiction recovery is reached. From the data given by the National Institute of Health; young adults have the highest cases or prevalence of developing mental health problems based on a self-assessment. However, this age group is also the least likely to seek professional help. Co-occurring disorders can be defined as; the mental state where a pre-existing mental health condition, usually one of a serious mental illness, is the leading factor for the contribution of another mental illness, usually one that is a comorbid substance use disorder. This means that there is a heavy correlation between the two conditions. Serious mental illnesses are where the cognition of the affected person has been impaired or interfered with because of how one feels. The focus of this paper surrounds opioid addiction or medically referred to as opioid use disorder. The reason for this focus is because of how highly addictive and strong the feeling of pain relief can be after using opioids continuously.

Keywords

Addiction Drug Use Mental Health

Article Details

How to Cite
Harris, N. (2023). Uncovering an Epidemic Co-occurrence in Opioid Use Disorder. Convergence Chronicles, 4(1), 34–45. https://doi.org/10.53075/Ijmsirq/65676587 (Original work published August 6, 2022)

References

  1. Diana, Marco. “The Dopamine Hypothesis of Drug Addiction and Its Potential
  2. Therapeutic Value.” Frontiers, 29 November 2011, https://www.frontiersin.org/articles/10.3389/fpsyt.2011.00064/full. Accessed 13 December 2021.
  3. HHS. “Home About the Epidemic Opioid Crisis Statistics.” HHS.gov, 2019,
  4. https://www.hhs.gov/opioids/about-the-epidemic/opioid-crisis-statistics/index.html. Accessed 28 March 2022.
  5. James, Christopher M., and Elinore F. McCance-Katz. “Co-occurring substance use and
  6. mental disorders among adults with opioid use disorder.” pubmed.gov, 14th February 2019, https://pubmed.ncbi.nlm.nih.gov/30784952/. Accessed 8th November 2021.
  7. Mayo Clinic. “Depression (major depressive disorder) - Symptoms and causes.” Mayo
  8. Clinic, 3 February 2018, https://www.mayoclinic.org/diseases-conditions/depression/symptoms-causes/syc-20356007. Accessed 28 March 2022.
  9. Mayo Clinic Staff. “How opioid addiction occurs.” Mayo Clinic, 16 February 2018,
  10. https://www.mayoclinic.org/diseases-conditions/prescription-drug-abuse/in-depth/how-opioid-addiction-occurs/art-20360372. Accessed 28 March 2022.
  11. National Institute on Drug Abuse. “How do other mental health conditions relate to
  12. substance use in adolescents?” National Institute on Drug Abuse, NIH, 2 June 2020, https://www.drugabuse.gov/publications/principles-adolescent-substance-use-disorder-treatment-research-based-guide/frequently-asked-questions/how-do-other-mental-health-conditions-relate-to-substance-use-in-adolescents. Accessed 20 December 2021.
  13. National Institute on Drug Abuse. “Metal Health.” NIDA for Teens, 15th March 2021,
  14. https://teens.drugabuse.gov/drug-facts/mental-health#topic-3. Accessed 4th November 2021.
  15. NIDA. "Say What? “Dopamine”." National Institute on Drug Abuse, 13 May. 2019,
  16. https://archives.drugabuse.gov/blog/post/say-what-dopamine. Accessed 28 Mar. 2022. NIDA. “The Brain and Addiction, Drug Facts, Effects.” National Institute on Drug Abuse, 15th March 2021, https://teens.drugabuse.gov/drug-facts/brain-and-addiction. Accessed 11th October 2021.
  17. National Institute on Drug Abuse. “What are the treatments for comorbid substance use
  18. disorder and mental health conditions?” National Institute on Drug Abuse, NIH, 14 April 2020, https://www.drugabuse.gov/publications/research-reports/common-comorbidities-substance-use-disorders/what-are-treatments-comorbid-substance-use-disorder-mental-health-conditions. Accessed 20 December 2021.
  19. NIMH. “NIMH » Mental Illness.” National Institute of Mental Health, January 2022,
  20. https://www.nimh.nih.gov/health/statistics/mental-illness. Accessed 28 March 2022. SAMHSA. “Living Well with Serious Mental Illness.” SAMHSA, 3 March 2022, https://www.samhsa.gov/serious-mental-illness. Accessed 28 March 2022.
  21. SAMHSA. “National Survey on Drug Use and Health | CBHSQ Data.” SAMHSA, 2022,
  22. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health. Accessed 28 March 2022.
  23. J McDonald, PhD, DG Lambert, PhD FRCA, Opioid receptors, BJA Education, Volume
  24. , Issue 5, October 2015, Pages 219–224, https://doi.org/10.1093/bjaceaccp/mku041.
  25. Koob, George F. Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia,
  26. and Negative Reinforcement. Elsevier Inc on behalf of Society of Biological Psychiatry, 2020. www.sobp.org/journal, file:///media/fuse/drivefs-d8432b0c70c1ff5223ce77cd8e79c549/root/Koob%202020%20(1).pdf. Accessed 19th November 2021.
  27. Uloth, Jaclyn. “Long- and Short-Term Effects of Opioid Abuse - Pinelands.” Pinelands
  28. Recovery Center, N/A, https://www.pinelandsrecovery.com/long-and-short-term-effects-of-opioid-abuse/. Accessed 28 March 2022.